Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About Larry Hsu

Larry Hsu Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Larry Hsu News

Larry Hsu 2.0: Generic drug trailblazer's new branded drug company targets rare tumors and more

Dec 15, 2021

"When I drive, I don't look at the rearview mirror," the AmMax Bio chairman and CEO said. "I drive forward."

Larry Hsu Investments

1 Investments

Larry Hsu has made 1 investments. Their latest investment was in Armetheon as part of their Series A on August 8, 2014.

CBI Logo

Larry Hsu Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/28/2014

Series A

Armetheon

$7M

Yes

4

Date

8/28/2014

Round

Series A

Company

Armetheon

Amount

$7M

New?

Yes

Co-Investors

Sources

4

Larry Hsu Portfolio Exits

1 Portfolio Exit

Larry Hsu has 1 portfolio exit. Their latest portfolio exit was Armetheon on March 30, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/30/2017

Merger

1

Date

3/30/2017

Exit

Merger

Companies

Valuation

Acquirer

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.